NCT03823820 (BiPAL) is a clinical trial of Bioimpedance Analyser in Hydration, sponsored by University Hospitals, Leicester.

Who is sponsoring NCT03823820?

NCT03823820 is sponsored by University Hospitals, Leicester.

What drugs are being tested in NCT03823820?

Interventions in NCT03823820: Bioimpedance Analyser.

Is NCT03823820 still recruiting?

NCT03823820 is currently recruiting now. Last updated 5 January 2026.

Last reviewed 2026-01-05 · How we verify

NCT03823820: BiPAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bioimpedance In Pregnancy and Labour: A Fluid Balance Concept Study.

Recruiting now Last updated 5 January 2026

What this trial tests

trial testing Bioimpedance Analyser in Hydration in 900 participants. Currently enrolling.

Timeline

8 April 2019

Primary endpoint
14 February 2029

14 February 2029

Quick facts

Lead sponsor	University Hospitals, Leicester
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	900
Start date	8 April 2019
Primary completion	14 February 2029
Estimated completion	14 February 2029
Sites	1 location across United Kingdom

Drugs / interventions tested

Bioimpedance Analyser

Conditions studied

Hydration — all drugs for Hydration →

Sponsor

University Hospitals, Leicester

Who can join

16 and older, female only, with Hydration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of our study is to find out if using a simple bed side test can tell us information about changes that occur in women's body water content. We would like to check if certain medical conditions could affect body water contents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hydration

Currently open trials in the same condition.

NCT07507344 — Beverage Hydration Index of Different Solutions · NA · recruiting
NCT07005895 — Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes · recruiting

Other University Hospitals, Leicester trials

Trials by the same sponsor.

NCT06179771 — Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support. · NA · recruiting
NCT06269172 — Perceptions Across Ethnicities to Develop an Adapted Intervention for Breathlessness · unknown
NCT06152406 — Ablate and Pace HIS Study · NA · recruiting
NCT06523192 — Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire · completed
NCT06025422 — In-shoe Pressures Associated With Footwear Fit Guidelines · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03823820 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospitals, Leicester
Last refreshed: 5 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03823820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing